You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Science this week: researchers find transplanting the gut microbiome in mice affects physiology, and more.
The system uses chemical epigenetic modifiers to activate the expression of target genes by recruiting an endogenous chromatin-activating machinery.
Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics.
In Science this week: a review says lifestyles of industrialized societies may be threatening needed gut microbial communities, and more.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
The prime editing technique has strengths that are complementary to nuclease-based editing and base editing.
NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.
The system uses the Cas13 nuclease to identify target sites in various RNA viruses and then destroy them.
The company said its test is faster, more precise, and cheaper than the current gold standard Cepheid GeneXpert test.
The researchers repurposed type I variants of class 1 CRISPR systems to make them usable for DNA targeting and transcriptional control.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.